DataCloudKnowledgetrainingcoordination

L1000 LINCS DCIC TAK002 A375 96H E16 MYCL2.tsv.gz (File)

Taxon:

Homo sapiens

Taxon (Entity type)

Subject:

A375

Subject (Entity type)

Project:

L1000-Phase1

Project (Entity type)

File Format:

TSV

File Format (Entity type)

Disease:

melanoma

Disease (Entity type)

Dcc Asset:

datapackage.zip

Processed File (Entity type)

Dcc:

LINCS

DCC (Entity type)

Data Type:

gene expression profile

Data Type (Entity type)

Compression Format:

GZIP format

File Format (Entity type)

Biosample:

L1000 LINCS DCIC TAK002 A375 96H E16 MYCL2

Biosample (Entity type)

Assay Type:

landmark transcript profiling assay

Assay Type (Entity type)

Anatomy:

skin of body

Anatomy (Entity type)

Uncompressed Size In Bytes:756 KB

Size In Bytes:277 KB

Sha256:f775e6e1b26806769e05d49c51dc300243c5033093dcb7452ae402326963b6b0

Persistent Id:drs://drs.lincs-dcic.org/39d1f2138cb4edad183e1f10c27ea269

Mime Type:application/gzip

Md5:39d1f2138cb4edad183e1f10c27ea269

Filename:L1000_LINCS_DCIC_TAK002_A375_96H_E16_MYCL2.tsv.gz

Creation Time:2017-03-03T00:00:00

Access Url:

drs://drs.lincs-dcic.org/39d1f2138cb4edad183e1f10c27ea269

Results found

Linked to

	Label	Description
	L1000 LINCS DCIC TAK002 A375 96H E16 MYCL2 Biosample (Entity type)	A biosample from LINCS produced as part of the L1000 Phase1 project

L1000 LINCS DCIC TAK002 A375 96H E16 MYCL2

Biosample (Entity type)

A biosample from LINCS produced as part of the L1000 Phase1 project

DISPLAY PER PAGE

Consortium

Community

Resources

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.